NCT07576725 2026-05-08Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialFred Hutchinson Cancer CenterPhase 2 Not yet recruiting50 enrolled